Entegrion Inc.
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jun 2022 | $14 M | No. 3 | $10 to $50 million | equity | SEC | |
| Oct 2015 | $7 M | No. 2 | $2 to $10 million | debt, options | SEC | |
| Sep 2010 | $1 M | No. 1 | Under $2 million | debt, options | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Entegrion Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2022).
SEC Form D · Jul 2022
The industry group it chose in its notices: Biotechnology.
SEC Form D · Jul 2022
That is all the official record says: Entegrion Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Entegrion Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 87 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Albert Valada | Executive officer | Jul 2022 |
| Richard Martin | Executive officer | Jul 2022 |
| Michael Galiger | Executive officer | May 2019 |
| Susan Reyer | Executive officer | May 2019 |
| Jeffery C. Basham | Executive officer | Mar 2011 |
| Joseph E. DaCorta | Executive officer | Mar 2011 |
| Richard E. Martin | Executive officer | Mar 2011 |
| Richard L. Kendall | Executive officer | Mar 2011 |
| Thomas L. Edwards | Executive officer | Mar 2011 |
| Albert Valada | Director | Jul 2022 |
| Brian Gibler | Director | Jul 2022 |
| Christopher Rumana | Director | Jul 2022 |
| J. True Martin | Director | Jul 2022 |
| Patrick Nash | Director | Jul 2022 |
| Pierre Noel | Director | Jul 2022 |
| Robert Capps | Director | Jul 2022 |
| Ronald Sacher | Director | Jul 2022 |
| Thomas Edwards | Director | Jul 2022 |
| J True Martin | Director | May 2019 |
| John Mowell | Director | May 2019 |
| Pierre Brian Noel | Director | May 2019 |
| Richard True Sacher | Director | May 2019 |
| Robert Brian Capps | Director | May 2019 |
| W Brian Gibler | Director | May 2019 |
| Romie Brian Brownlee | Director | Jul 2017 |
| William Corbitt | Director | Jul 2017 |
| John B. Mowell | Director | Mar 2011 |
| Les L. Brownlee | Director | Mar 2011 |
| Norman E. Thagard | Director | Mar 2011 |
| Patrick F. Nash | Director | Mar 2011 |
| Thomas L. Edwards | Director | Mar 2011 |
| William S. Corbitt, III | Director | Mar 2011 |
| Albert Valada | Promoter | Jul 2022 |
| Richard Martin | Promoter | Jul 2022 |